Tamara Saurí

526 total citations
30 papers, 226 citations indexed

About

Tamara Saurí is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Tamara Saurí has authored 30 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Tamara Saurí's work include Colorectal Cancer Treatments and Studies (11 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Treatment and Pharmacology (6 papers). Tamara Saurí is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Treatment and Pharmacology (6 papers). Tamara Saurí collaborates with scholars based in Spain, United States and Palestinian Territory. Tamara Saurí's co-authors include Teresa Macarulla, Helena Verdaguer, Cristina Oliveras‐Ferraros, Javier A. Menéndez, Sílvia Cufí, Alejandro Vázquez‐Martín, Eugeni López‐Bonet, Juan Antonio Virizuela Echaburu, J.M. González Gómez and Gloria Serrano and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Annals of Oncology.

In The Last Decade

Tamara Saurí

27 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamara Saurí Spain 9 107 65 49 45 41 30 226
Su‐Han Jin China 12 72 0.7× 112 1.7× 48 1.0× 61 1.4× 84 2.0× 31 319
A Bali Belgium 5 130 1.2× 58 0.9× 89 1.8× 90 2.0× 36 0.9× 5 313
Fiona Langlands United Kingdom 7 91 0.9× 70 1.1× 66 1.3× 56 1.2× 83 2.0× 11 250
Xiaojing Lu China 9 46 0.4× 95 1.5× 18 0.4× 59 1.3× 44 1.1× 20 241
Y. Kakeji Japan 10 109 1.0× 86 1.3× 115 2.3× 91 2.0× 23 0.6× 18 317
Zhaoxiu Liu China 10 57 0.5× 106 1.6× 52 1.1× 46 1.0× 41 1.0× 27 297
Gijs van Boxel United Kingdom 6 44 0.4× 100 1.5× 32 0.7× 40 0.9× 12 0.3× 12 277
Yasuteru Fujino Japan 10 118 1.1× 144 2.2× 70 1.4× 91 2.0× 90 2.2× 21 340
Xuezhu Wang China 9 132 1.2× 75 1.2× 99 2.0× 32 0.7× 63 1.5× 37 331
Liselot Valkenburg‐van Iersel Netherlands 8 122 1.1× 62 1.0× 80 1.6× 69 1.5× 17 0.4× 21 225

Countries citing papers authored by Tamara Saurí

Since Specialization
Citations

This map shows the geographic impact of Tamara Saurí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Saurí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Saurí more than expected).

Fields of papers citing papers by Tamara Saurí

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara Saurí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Saurí. The network helps show where Tamara Saurí may publish in the future.

Co-authorship network of co-authors of Tamara Saurí

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara Saurí. A scholar is included among the top collaborators of Tamara Saurí based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara Saurí. Tamara Saurí is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adeva, Jorge, et al.. (2025). SEOM-GEMCAD-TTD clinical guidelines for biliary tract cancer (2025). Clinical & Translational Oncology. 27(8). 3293–3306.
2.
3.
Pedrosa, Leire, Isis K. Araujo, Míriam Cuatrecasas, et al.. (2023). Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology. Frontiers in Molecular Biosciences. 10. 1161893–1161893. 3 indexed citations
4.
5.
Rodríguez, A., Laia Fernández‐Barat, F. Espósito, et al.. (2022). Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53–Mutated Metastatic Colorectal Cancer. Cancers. 14(23). 5921–5921. 3 indexed citations
6.
Herreros, Marta García de, F. Espósito, Tamara Saurí, & Carme Font. (2022). Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-paclitaxel. Journal of Oncology Pharmacy Practice. 29(3). 738–745.
7.
Montés, Ana Fernández, Guillermo de Velasco, Rodolfo Chicas-Sett, et al.. (2021). Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice. Current Treatment Options in Oncology. 22(3). 26–26. 6 indexed citations
8.
Ausania, Fabio, Santiago Sánchez-Cabús, Alex Borin, et al.. (2021). Clinical impact of preoperative tumour contact with superior mesenteric-portal vein in patients with resectable pancreatic head cancer. Langenbeck s Archives of Surgery. 406(5). 1443–1452. 6 indexed citations
9.
Rodríguez, A., Juan Moreno, F. Espósito, et al.. (2020). 476P Mutational profiling allows the stratification of metastatic colorectal cancer patients with poor prognosis. Annals of Oncology. 31. S443–S443. 1 indexed citations
10.
Mesı́a, Ricard, et al.. (2019). Opioid-Induced Constipation in Oncological Patients: New Strategies of Management. Current Treatment Options in Oncology. 20(12). 91–91. 27 indexed citations
11.
Verdaguer, Helena, Tamara Saurí, & Teresa Macarulla. (2017). Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment. Journal of Gastrointestinal Oncology. 8(3). 405–417. 22 indexed citations
12.
Matos, Ignacio, et al.. (2017). The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors. Targeted Oncology. 12(6). 757–774. 1 indexed citations
13.
14.
Grasselli, Julieta, Élena Elez, Enrique Sanz‐García, et al.. (2016). Molecular, clinical and prognostic characterization of double KRAS/PIK3CA (dKP) mutated metastatic colorectal cancer (mCRC). Annals of Oncology. 27. vi185–vi185. 1 indexed citations
15.
Saurí, Tamara, Teresa Macarulla, Helena Verdaguer, et al.. (2016). Comprehensive profiling of biliary tract cancers (BTC) to reveal molecular heterogeneity with implications for matched targeted therapies (MTT).. Journal of Clinical Oncology. 34(15_suppl). 4085–4085. 5 indexed citations
16.
Sanz‐García, Enrique, Tamara Saurí, Josep Tabernero, & Teresa Macarulla. (2015). Pharmacokinetic and pharmacodynamic evaluation of aflibercept for the treatment of colorectal cancer. Expert Opinion on Drug Metabolism & Toxicology. 11(6). 995–1004. 3 indexed citations
17.
Macarulla, Teresa, Tamara Saurí, & Josep Tabernero. (2014). Evaluation of aflibercept in the treatment of metastatic colorectal cancer. Expert Opinion on Biological Therapy. 14(10). 1493–1505. 8 indexed citations
18.
Garrido-Castro, Ana C., Tamara Saurí, & Teresa Macarulla. (2014). New Targets and New Drug Development in Colorectal Cancer. Current Colorectal Cancer Reports. 10(3). 288–295. 2 indexed citations
19.
Vázquez‐Martín, Alejandro, Tamara Saurí, Cristina Oliveras‐Ferraros, et al.. (2012). Ser2481-autophosphorylated mTOR colocalizes with chromosomal passenger proteins during mammalian cell cytokinesis. Cell Cycle. 11(22). 4211–4221. 17 indexed citations
20.
Oliveras‐Ferraros, Cristina, Alejandro Vázquez‐Martín, Sílvia Cufí, et al.. (2011). Inhibitor of Apoptosis (IAP) survivin is indispensable for survival of HER2 gene-amplified breast cancer cells with primary resistance to HER1/2-targeted therapies. Biochemical and Biophysical Research Communications. 407(2). 412–419. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Su‐Han Jin Breakdown of academic impact, for papers by A Bali Breakdown of academic impact, for papers by Fiona Langlands Breakdown of academic impact, for papers by Xiaojing Lu Breakdown of academic impact, for papers by Y. Kakeji Breakdown of academic impact, for papers by Zhaoxiu Liu Breakdown of academic impact, for papers by Gijs van Boxel Breakdown of academic impact, for papers by Yasuteru Fujino Breakdown of academic impact, for papers by Xuezhu Wang Breakdown of academic impact, for papers by Liselot Valkenburg‐van Iersel
Rankless by CCL
2026